Fulcrum Therapeutics
FULC
#6285
Rank
โ‚ฌ0.71 B
Marketcap
10,90ย โ‚ฌ
Share price
-7.25%
Change (1 day)
168.31%
Change (1 year)

Revenue for Fulcrum Therapeutics (FULC)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of โ‚ฌ76.87 Million an increase over the revenue in the year 2023 that were of โ‚ฌ2.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fulcrum Therapeutics from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 โ‚ฌ76.87 M2929.77%
2023 โ‚ฌ2.53 M-57.08%
2022 โ‚ฌ5.91 M-65.06%
2021 โ‚ฌ16.92 M135.89%
2020 โ‚ฌ7.17 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA